Stay updated on SBRT +/- Pembrolizumab in Head and Neck Carcinoma Clinical Trial

Sign up to get notified when there's something new on the SBRT +/- Pembrolizumab in Head and Neck Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SBRT +/- Pembrolizumab in Head and Neck Carcinoma Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Added a consolidated Locations section listing Arizona, Florida, Kentucky, Massachusetts, Michigan, Missouri, New York, Ohio, Pennsylvania, Texas, Wisconsin, Alberta, and Quebec; removed the prior individual location subsections; version updated to v3.3.3.
    Difference
    1%
    Check dated 2025-12-23T09:14:50.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    35 days ago
    Change Detected
    Summary
    Revision history update: added Revision v3.3.2 and removed Revision v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T16:58:45.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Removed the government funding lapse notice from the page; trial details, contacts, and locations remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T15:00:48.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    No significant additions or deletions were detected on the page. The study overview and key sections remain unchanged.
    Difference
    0.3%
    Check dated 2025-11-03T01:31:51.000Z thumbnail image
  7. Check
    86 days ago
    Change Detected
    Summary
    Key updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. If no other substantive content changed, this is a minor but status/reliability-related update.
    Difference
    2%
    Check dated 2025-10-05T10:34:31.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    Added extensive contact details (phones/emails) and a new version tag; removed a specific resource entry about head and neck squamous cell carcinoma. Overall, a shift toward updating people/organization identifiers and versioning, with a minor removal of a resource reference.
    Difference
    0.4%
    Check dated 2025-09-28T03:24:20.000Z thumbnail image

Stay in the know with updates to SBRT +/- Pembrolizumab in Head and Neck Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SBRT +/- Pembrolizumab in Head and Neck Carcinoma Clinical Trial page.